Pharma Industry News June 30 2023 – 9 highly anticipated FDA decisions in second half of 2023 10 months ago
Healthcare News • Pharma Industry News New approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction 10 months ago
New Drugs FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) Gene Therapy for Adults with Severe Hemophilia A 10 months ago
Healthcare News • Pharma Industry News Proteins predict significant step toward development of diabetes 10 months ago
New Drugs FDA Approves Lantidra (donislecel-jujn) Cellular Therapy to Treat Patients with Type 1 Diabetes 10 months ago
New Drugs FDA Approves Ngenla (somatrogon-ghla) Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency 10 months ago
Healthcare News • Pharma Industry News Bayer's new pharmaceutical R&D strategy to accelerate breakthrough innovations 10 months ago
New Drugs FDA Approves Rystiggo (rozanolixizumab-noli) for the Treatment of Adults with Generalized Myasthenia Gravis 10 months ago
Healthcare News • Pharma Industry News FDA accepts Pfizer's application for hemophilia B gene therapy fidanacogene elaparvovec 10 months ago
Healthcare News • Pharma Industry News Higher doses of oral semaglutide improves blood sugar control and weight loss 10 months ago